Susanne Lingelbach

450 total citations
13 papers, 348 citations indexed

About

Susanne Lingelbach is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Susanne Lingelbach has authored 13 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 3 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Genetics. Recurrent topics in Susanne Lingelbach's work include Angiogenesis and VEGF in Cancer (5 papers), Estrogen and related hormone effects (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Susanne Lingelbach is often cited by papers focused on Angiogenesis and VEGF in Cancer (5 papers), Estrogen and related hormone effects (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Susanne Lingelbach collaborates with scholars based in Germany and Austria. Susanne Lingelbach's co-authors include A. Zielke, Sebastian Hoffmann, A. Wunderlich, Lorenz C. Hofbauer, Pietro Di Fazio, Matthias Ocker, Daniel Neureiter, Roberta Montalbano, Beate Alinger and Felix Rückert and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Annals of Surgical Oncology and Oncotarget.

In The Last Decade

Susanne Lingelbach

13 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Susanne Lingelbach Germany	10	168	139	128	57	43	13	348
Xiaomai Zhou China	4	353 2.1×	117 0.8×	160 1.3×	110 1.9×	26 0.6×	7	469
Gioia Iezza United States	7	166 1.0×	146 1.1×	129 1.0×	34 0.6×	35 0.8×	9	320
Fabio De Martino Switzerland	8	136 0.8×	94 0.7×	65 0.5×	104 1.8×	51 1.2×	12	305
Andrew Brandmaier United States	13	143 0.9×	97 0.7×	44 0.3×	62 1.1×	35 0.8×	24	378
Roberta Poli Italy	8	335 2.0×	138 1.0×	195 1.5×	29 0.5×	41 1.0×	10	518
Cédric Cortijo Switzerland	5	193 1.1×	55 0.4×	80 0.6×	42 0.7×	41 1.0×	7	321
Xinwei Yun China	11	345 2.1×	99 0.7×	133 1.0×	147 2.6×	24 0.6×	21	509
Gregory Miles United States	5	199 1.2×	88 0.6×	37 0.3×	117 2.1×	46 1.1×	5	345
Florencia Cayrol Argentina	11	173 1.0×	192 1.4×	72 0.6×	41 0.7×	57 1.3×	17	375
Emma T. Lundsmith United States	7	320 1.9×	198 1.4×	245 1.9×	160 2.8×	47 1.1×	7	610

Countries citing papers authored by Susanne Lingelbach

Since Specialization

Citations

This map shows the geographic impact of Susanne Lingelbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susanne Lingelbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susanne Lingelbach more than expected).

Fields of papers citing papers by Susanne Lingelbach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susanne Lingelbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susanne Lingelbach. The network helps show where Susanne Lingelbach may publish in the future.

Co-authorship network of co-authors of Susanne Lingelbach

This figure shows the co-authorship network connecting the top 25 collaborators of Susanne Lingelbach. A scholar is included among the top collaborators of Susanne Lingelbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susanne Lingelbach. Susanne Lingelbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Heers, Hendrik, et al.. (2022). Soluble PD-L1 in blood correlates positively with neutrophil and negatively with lymphocyte mRNA markers and implies adverse sepsis outcome. Immunologic Research. 70(5). 698–707. 11 indexed citations

Keber, Corinna U., Carolin Schultz, Susanne Lingelbach, et al.. (2022). Cellular and soluble immune checkpoint signaling forms PD-L1 and PD-1 in renal tumor tissue and in blood. Cancer Immunology Immunotherapy. 71(10). 2381–2389. 6 indexed citations

Hänze, Jörg, Peter Rexin, Hendrik Heers, et al.. (2018). Prostate cancer tissues with positive TMPRSS2-ERG-gene-fusion status may display enhanced nerve density. Urologic Oncology Seminars and Original Investigations. 38(1). 3.e7–3.e15. 10 indexed citations

Fazio, Pietro Di, Petra Waldegger, Samir Jabari, et al.. (2016). Autophagy-related cell death by pan-histone deacetylase inhibition in liver cancer. Oncotarget. 7(20). 28998–29010. 38 indexed citations

Fazio, Pietro Di, Susanne Lingelbach, Rainer Schobert, & Bernhard Biersack. (2014). 4,5-Diaryl imidazoles with hydroxamic acid appendages as anti-hepatoma agents. Investigational New Drugs. 33(1). 104–108. 4 indexed citations

Quint, Karl, Pietro Di Fazio, Roberta Montalbano, et al.. (2012). Pancreatic cancer cells surviving gemcitabine treatment express markers of stem cell differentiation and epithelial-mesenchymal transition. International Journal of Oncology. 41(6). 2093–2102. 71 indexed citations

Hoffmann, Sebastian, Annette Wunderlich, Susanne Lingelbach, et al.. (2008). Expression and Secretion of Endostatin in Thyroid Cancer. Annals of Surgical Oncology. 15(12). 3601–3608. 5 indexed citations

Hoffmann, Sebastian, Andreas Burchert, A. Wunderlich, et al.. (2007). Differential effects of cetuximab and AEE 788 on epidermal growth factor receptor (EGF-R) and vascular endothelial growth factor receptor (VEGF-R) in thyroid cancer cell lines. Endocrine. 31(2). 105–113. 30 indexed citations

Hoffmann, Sebastian, Scott Glaser, A. Wunderlich, et al.. (2006). Targeting the EGF/VEGF-R system by tyrosine-kinase inhibitors—a novel antiproliferative/antiangiogenic strategy in thyroid cancer. Langenbeck s Archives of Surgery. 391(6). 589–596. 27 indexed citations

10.

Hoffmann, Sebastian, Katja Maschuw, I. Hassan, et al.. (2006). Functional Thyrotropin Receptor Attenuates Malignant Phenotype of Follicular Thyroid Cancer Cells. Endocrine. 30(1). 129–138. 15 indexed citations

11.

Hoffmann, Sebastian, A. Ramaswamy, İ. Çeli̇k, et al.. (2006). Retinoic acid inhibits angiogenesis and tumor growth of thyroid cancer cells. Molecular and Cellular Endocrinology. 264(1-2). 74–81. 45 indexed citations

12.

Hoffmann, Sebastian, Katja Maschuw, I. Hassan, et al.. (2005). Differential Pattern of Integrin Receptor Expression in Differentiated and Anaplastic Thyroid Cancer Cell Lines. Thyroid. 15(9). 1011–1020. 26 indexed citations

13.

Hoffmann, Sebastian, et al.. (2004). Thyrotropin (TSH)-Induced Production of Vascular Endothelial Growth Factor in Thyroid Cancer Cellsin Vitro: Evaluation of TSH Signal Transduction and of Angiogenesis-Stimulating Growth Factors. The Journal of Clinical Endocrinology & Metabolism. 89(12). 6139–6145. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact